Collegium Pharmaceutical (COLL) EV to CFO (2015 - 2026)

Collegium Pharmaceutical has reported EV to CFO for 12 years, with the latest figure at 14.4 in Q2 2026.

• On a quarterly basis, EV to CFO rose 46.77% year-over-year to 14.4 in Q2 2026; TTM through Jun 2026 was 3.11, a 10.87% decrease from a year earlier, with the FY2025 full-year figure at 3.28, down 8.8% from the prior year.
• EV to CFO was 14.4 for Q2 2026 at Collegium Pharmaceutical, up from 11.38 in the prior quarter.
• The five-year high for EV to CFO was 20.24 in Q1 2023, with the low at 125.06 in Q3 2024.
• Average EV to CFO over 5 years is 1.45, with a median of 9.66 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EV to CFO soared 187.75% in 2023, then sank 2231.06% in 2024.
• Over 5 years, EV to CFO stood at 9.22 in 2022, then slipped by 0.87% to 9.14 in 2023, then slipped by 4.62% to 8.72 in 2024, then climbed by 0.8% to 8.79 in 2025, then jumped by 63.87% to 14.4 in 2026.
• The last three EV to CFO figures came in at 14.4 (Q2 2026), 11.38 (Q1 2026), and 8.79 (Q4 2025), per Business Quant data.